Background: During active ulcerative colitis (UC), vast numbers of granulocytes, monocytes/macrophages (GM) infiltrate the mucosal tissue and can potentially exacerbate inflammation and injury. Accordingly, we were interested to see if selective depletion of GM by adsorption (GMA) impacts mucosal he
Hepatic injury during ketoconazole therapy in patients with onychomycosis: A controlled cohort study
β Scribed by R. Chien; L. Yang; P. Lin; Y. Liaw
- Publisher
- John Wiley and Sons
- Year
- 1997
- Tongue
- English
- Weight
- 665 KB
- Volume
- 25
- Category
- Article
- ISSN
- 0270-9139
No coin nor oath required. For personal study only.
β¦ Synopsis
duced hepatitis is often diagnosed by exclusion, so that the To evaluate the incidence, severity, and course of ketopossibility of hepatitis C virus (HCV) infection has not been conazole-associated hepatic injury, 211 patients with excluded in most reports, because serological markers for onychomycosis were randomized by a ratio of 2:1 to re-HCV were not available before 1989. 27 Therefore, we have ceive either ketoconazole (137 patients) or griseofulvin conducted this controlled, cohort study to examine the inci-(74 patients). All of them were seronegative for hepatitis dence, severity, and clinical course of ketoconazole-induced B surface antigen (HBsAg) and anti-hepatitis C virus hepatic injury. (HCV) and had no biochemical abnormality before therapy. The two groups were comparable in age, sex, and PATIENTS AND METHODS pretherapy liver biochemical tests. Liver biochemical
π SIMILAR VOLUMES
Recent studies performed in Japan have suggested that hepatitis C virus (HCV) genome heterogeneity might be taken as a predictive virological parameter of response to interferon alfa (IFN-alpha) treatment. However, there is presently no information on the impact of this virological parameter in pati
We examined the feasibility of hepatitis C treatment in patients on opioid maintenance. One hundred patients with chronic hepatitis C, 50 on methadone maintenance, and 50 with no intravenous drug use or opioid maintenance for at least 5 years were prospectively matched for sex, age, hepatitis C viru